EUVIMEDEUVIMED entdecken
Crossref

Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa

Piroonrat Dechbumroong, Sarawut Lapmanee, Wisawat Keaswejjareansuk, Thunyatorn Yimsoo, Worapapar Treesuppharat, Apipu Ariyachayut, Xing-Jie Liang, Katawut Namdee, Mengliang Zhu

European Journal of Pharmaceutics and Biopharmaceutics · 2026-07 · 224 · 115089

DOI: 10.1016/j.ejpb.2026.115089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-07. Verfasst von Piroonrat Dechbumroong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, Na…. Hauptthemen laut MEDLINE: Nasal Mucosa, RNA, Messenger, Liposomes, Transfection. Die Arbeit nennt 147 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, National Nanotechnology Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intranasal mRNA therapeutic design represents a compelling strategy by offering a minimally invasive delivery route that concentrates mRNA activity at the nasal mucosa, promotes localized biological responses, and limits systemic distribution and first-pass metabolism. However, biological barriers such as the mucus layer remain significant obstacles to effective delivery. In this study, we developed an intranasal mRNA delivery platform based on non-PEGylated cationic liposomes composed of SPC, DPPC, cholesterol, and DDAB, fabricated using a microfluidic approach. Among the tested formulations, B4 lipoplexes (SPC, DPPC, cholesterol, and DDAB at a 2:3:1:0.5 M ratio) demonstrated desired properties, including a positive surface charge of +21.0 mV, a particle size of 140 nm, a low polydispersity (0.28), and as high as 84% mRNA encapsulation. The lipoplexes were systematically evaluated for physicochemical characteristics, mucoadhesiveness, mucus penetration, in vitro cell viability and uptake, and transfection efficiency both in vitro and in vivo. The formulation demonstrated strong mucoadhesive behavior while maintaining efficient mucus penetration. Fluorescence imaging confirmed robust cellular uptake and successful cytosolic mRNA delivery, resulting in high transfection efficiency. Notably, the lipoplexes encapsulating GFP and SARS-CoV-2 Omicron spike protein mRNA achieved efficient in vitro transfection with minimal cytotoxicity in A549 and HEK293T cells, as confirmed by MTT assay. Importantly, the lipoplexes containing 0.25-2 µg mRNA did not trigger significant pro-inflammatory cytokine responses (IL-1β, IL-6, TNF-α, and MCP-1) in THP-1 cells. Following intranasal administration in C57BL/6 mice, firefly luciferase mRNA-loaded B4 lipoplexes exhibited efficient adhesion to and penetration through nasal mucus, facilitated transfection of cells lining the nasal cavity, and produced localized reporter protein expression without detectable off-target expression. Collectively, these findings highlighted the strong potential of the non-PEGylated cationic lipoplexes as a safe and effective intranasal mRNA delivery platform, offering a noninvasive targeting strategy that broadens the applicability of lipid-based mRNA therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal MucosaRNA, MessengerLiposomesTransfectionNanoparticlesAnimalsCationsHumansAdministration, IntranasalMiceParticle SizeCell SurvivalCholesterolMice, Inbred C57BLMale

Stichwörter der Autor:innen

Cationic liposomesIntranasal administrationNasal deliveryNon-PEGylated liposomesmRNA delivery system

Substanzen

RNA, MessengerLiposomesCationsCholesterol

Autor:innen und Institutionen

  • Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China. Beijing 100190,…
  • Chulabhorn International College of Medicine, Thammasat University, Khlong Luang, Pathum Thani 12120, Thailand.
  • National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency, Pathum Thani 12120, Thailand.
  • Laboratory Animal Center, Office of Advanced Science and Technology, Thammasat University, Pathumthani 12120, Thailand; Thammasat University Research Unit in Mechanisms of Drug Action and Molecular Imaging, Drug Discove…
  • Thammasat University Research Unit in Mechanisms of Drug Action and Molecular Imaging, Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathumthani 12120 Thailand.
  • National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency, Pathum Thani 12120, Thailand. Electronic address: katawut@nanotec.or.th.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality
  • National Nanotechnology Center
  • National Key Research and Development Program of China

Zitieren

APA

Dechbumroong, P., Lapmanee, S., Keaswejjareansuk, W., Yimsoo, T., Treesuppharat, W., Ariyachayut, A., Liang, X. J., Namdee, K., & Zhu, M. (2026). Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa. European Journal of Pharmaceutics and Biopharmaceutics, 224, 115089. https://doi.org/10.1016/j.ejpb.2026.115089

Vancouver

Dechbumroong P, Lapmanee S, Keaswejjareansuk W, Yimsoo T, Treesuppharat W, Ariyachayut A, et al. Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa. European Journal of Pharmaceutics and Biopharmaceutics. 2026;224:115089. doi:10.1016/j.ejpb.2026.115089

BibTeX
@article{Dechbumroong2026,
  author = {Dechbumroong, Piroonrat and Lapmanee, Sarawut and Keaswejjareansuk, Wisawat and Yimsoo, Thunyatorn and Treesuppharat, Worapapar and Ariyachayut, Apipu and Liang, Xing-Jie and Namdee, Katawut and Zhu, Mengliang},
  title = {Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  volume = {224},
  pages = {115089},
  doi = {10.1016/j.ejpb.2026.115089}
}
Kostenlos starten →